Theriva Biologics (FRA:SFY0) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SFY0 Theriva Biologics Inc FRA:SFY0
26 GF Score
Price €2.42
! 3 Warning Signs
View Full Analysis

What is Theriva Biologics FFO per Share?

FFO per Share only applies to REITs.

FRA:SFY0
26GF Score
Theriva Biologics Inc FRA:SFY0
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Theriva Biologics Business Description

Other Exchanges TOVX:USA
Address 9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
26GF Score

Get the complete analysis for FRA:SFY0

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price